Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Inhibition of hyaluronic acid degradation pathway suppresses glioma progression by inducing apoptosis and cell cycle arrest

Fig. 5

HYAL2 knockdown has a satisfactory therapeutic outcome in glioma. (A) The viability of U251 and LN229 cell lines treated with siHYAL2 for 48 h was detected by MTT assay. (B-C) The proliferation viability of U251 and LN229 cell lines treated with siHYAL2 for 48 h detected by EdU assay. Scale bar: 100 μm (D) The proliferation viability of U251 treated with siHYAL2 detected by colony formation assay. Bars represent the mean ± SD; *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page